| C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis I Huang, R Pranata, MA Lim, A Oehadian, B Alisjahbana Therapeutic advances in respiratory disease 14, 1753466620937175, 2020 | 778 | 2020 |
| The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis B Alisjahbana, E Sahiratmadja, EJ Nelwan, AM Purwa, Y Ahmad, ... Clinical infectious diseases 45 (4), 428-435, 2007 | 596 | 2007 |
| Clinical trial registration: looking back and moving ahead C Laine, R Horton, CD DeAngelis, JM Drazen, FA Frizelle, F Godlee, ... The Lancet 369 (9577), 1909-1911, 2007 | 505 | 2007 |
| Implications of the global increase of diabetes for tuberculosis control and patient care R Ruslami, RE Aarnoutse, B Alisjahbana, AJAM Van Der Ven, ... Tropical Medicine & International Health 15 (11), 1289-1299, 2010 | 382 | 2010 |
| Genetic Association and Expression Studies Indicate a Role of Toll-Like Receptor 8 in Pulmonary Tuberculosis S Davila, ML Hibberd, R Hari Dass, HEE Wong, E Sahiratmadja, ... PLoS genetics 4 (10), e1000218, 2008 | 337 | 2008 |
| Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes HMJ Nijland, R Ruslami, JE Stalenhoef, EJ Nelwan, B Alisjahbana, ... Clinical Infectious Diseases 43 (7), 848-854, 2006 | 337 | 2006 |
| Diabetes mellitus is strongly associated with tuberculosis in Indonesia B Alisjahbana, R Van Crevel, E Sahiratmadja, M den Heijer, A Maya, ... The international journal of tuberculosis and lung disease 10 (6), 696-700, 2006 | 337 | 2006 |
| Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis THM Ottenhoff, RH Dass, N Yang, MM Zhang, HEE Wong, E Sahiratmadja, ... Public Library of Science 7 (9), e45839, 2012 | 266 | 2012 |
| Clinical management of concurrent diabetes and tuberculosis and the implications for patient services AL Riza, F Pearson, C Ugarte-Gil, B Alisjahbana, S Van de Vijver, ... The lancet Diabetes & endocrinology 2 (9), 740-753, 2014 | 265 | 2014 |
| Dynamic changes in pro-and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to … E Sahiratmadja, B Alisjahbana, T de Boer, I Adnan, A Maya, ... Infection and immunity 75 (2), 820-829, 2007 | 254 | 2007 |
| Common variants at 11p13 are associated with susceptibility to tuberculosis T Thye, E Owusu-Dabo, FO Vannberg, R Van Crevel, J Curtis, ... Nature genetics 44 (3), 257-259, 2012 | 246 | 2012 |
| Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients R Ruslami, HMJ Nijland, B Alisjahbana, I Parwati, R van Crevel, ... Antimicrobial agents and chemotherapy 51 (7), 2546-2551, 2007 | 240 | 2007 |
| Early clearance of Mycobacterium tuberculosis: a new frontier in prevention AJ Verrall, M G. Netea, B Alisjahbana, PC Hill, R van Crevel Immunology 141 (4), 506-513, 2014 | 218 | 2014 |
| The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus JE Stalenhoef, B Alisjahbana, EJ Nelwan, J Van der Ven-Jongekrijg, ... European Journal of Clinical Microbiology & Infectious Diseases 27, 97-103, 2008 | 214 | 2008 |
| Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia KR Porter, CG Beckett, H Kosasih, RI Tan, B Alisjahbana, PIF Rudiman, ... The American journal of tropical medicine and hygiene 72 (1), 60-66, 2005 | 210 | 2005 |
| Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis HMJ Nijland, R Ruslami, AJ Suroto, DM Burger, B Alisjahbana, ... Clinical infectious diseases 45 (8), 1001-1007, 2007 | 198 | 2007 |
| Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes R Ruslami, HMJ Nijland, IGN Adhiarta, SHKS Kariadi, B Alisjahbana, ... Antimicrobial agents and chemotherapy 54 (3), 1068-1074, 2010 | 176 | 2010 |
| A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians E Png, B Alisjahbana, E Sahiratmadja, S Marzuki, R Nelwan, ... BMC medical genetics 13, 1-9, 2012 | 137 | 2012 |
| Diabetes mellitus among pulmonary tuberculosis patients from 4 tuberculosis-endemic countries: the TANDEM study C Ugarte-Gil, B Alisjahbana, K Ronacher, AL Riza, RC Koesoemadinata, ... Clinical Infectious Diseases 70 (5), 780-788, 2020 | 119 | 2020 |
| The C-type lectin receptor CLECSF8/CLEC4D is a key component of anti-mycobacterial immunity GJ Wilson, MJ Marakalala, JC Hoving, A Van Laarhoven, RA Drummond, ... Cell host & microbe 17 (2), 252-259, 2015 | 118 | 2015 |